Early studies suggest that GLP-1 agonists, such as exenatide and liraglutide, may reduce breast cancer cell proliferation and viability by altering cellular energy metabolism
This expert-backed guide covers how it works, who its for, and what kind of results you can expect
If youre concerned, reach out to your clinician
Nindrea, R
Who is a candidate, and who is not Inquire about preferred smoothness of recovery, four- to six-week daily self-injection capability and documented health history for tolerance
therefore, some patients may have difficulty with spitting, whistling, eating with a spoon, drinking through a straw, rubbing lips together, and pronouncing certain words. All of the aforementioned side effects will self-resolve, and you can expect full results after 14 days